X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
https://www.globenewswire.com//news-release/2023/01/05/2583508/0/en/Amryt-Announces-Positive-Top-Line-Results-from-Phase-3-Pediatric-Trial-of-Lomitapide-in-HoFH.html
https://endpts.com/coming-out-of-chapter-11-aegerion-jumps-into-welcome-arms-of-irish-pharma-with-big-plans-fresh-60m-for-its-drugs/
https://pharmaphorum.com/news/evinacumab-regeneron-cholesterol-drug-trial/
https://endpts.com/armed-with-stellar-if-niche-phiii-data-regeneron-steers-breakthrough-cholesterol-drug-to-post-pcsk9-waters/
https://pharmaphorum.com/news/amryt-to-expand-rare-disease-portfolio-with-311m-aegerion-merger/
https://pharmaphorum.com/news/nhs-england-okays-funding-for-cholesterol-lowering-drug-lojuxta/
https://www.forbes.com/sites/nicolefisher/2018/06/26/sticker-shock-the-real-cost-of-americas-10-most-expensive-drugs/?ss=pharma-healthcare#1781663714d1
https://www.reuters.com/article/us-novelion-therape-settlement/u-s-judge-sentences-novelions-aegerion-in-drug-marketing-case-idUSKBN1FJ2ZG?utm_campaign=trueAnthem:+Trending+Content&utm_content=5a714faa04d3015e18b3bf2f&utm_medium=trueAnthem&utm_source=twitter
http://www.pharmatimes.com/news/aegerion_pleads_guilty_to_us_marketing_violations_1206330
https://globenewswire.com/news-release/2016/12/16/898393/0/en/Novelion-Therapeutics-Subsidiary-Launches-JUXTAPID-lomitapide-in-Japan.html
https://globenewswire.com/news-release/2016/11/29/893578/0/en/Aegerion-Pharmaceuticals-Inc-and-QLT-Inc-Complete-Merger-Transaction-QLT-to-Change-Name-to-Novelion-Therapeutics-Inc.html
http://www.fiercepharma.com/story/aegerion-names-mary-szela-ceo-replace-controversial-and-overly-talkative-ma/2016-01-08
Market Place
Share 
